MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

RV Lalla, J Bowen, A Barasch, L Elting, J Epstein… - Cancer, 2014 - Wiley Online Library
BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …

Oral complications of cancer and cancer therapy: from cancer treatment to survivorship

JB Epstein, J Thariat, RJ Bensadoun… - CA: a cancer journal …, 2012 - Wiley Online Library
Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

[HTML][HTML] Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience

AT Sougiannis, BN VanderVeen… - American Journal …, 2021 - journals.physiology.org
Intestinal mucositis remains one of the most debilitating side effects related to
chemotherapy. The onset and persistence of mucositis is an intricate physiological process …

Role of antioxidants in cancer therapy

V Fuchs-Tarlovsky - Nutrition, 2013 - Elsevier
Oxidative stress is a key component in linking environmental toxicity to the multistage
carcinogenic process. Reactive oxygen species (ROS) are generated in response to both …

Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?

S Otto, S Hafner, G Mast, T Tischer, E Volkmer… - Journal of Oral and …, 2010 - Elsevier
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a side effect of
bisphosphonate therapy, primarily diagnosed in patients with cancer and metastatic bone …

Metal complex strategies for photo-uncaging the small molecule bioregulators nitric oxide and carbon monoxide

PC Ford - Coordination Chemistry Reviews, 2018 - Elsevier
Photochemical release (uncaging) of small molecule bioregulators (SMBs) such as nitric
oxide (NO) or carbon monoxide (CO) at physiological sites offers exquisite control of timing …

Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation

JSY Tam, JK Coller, PA Hughes, CA Prestidge… - Indian Journal of …, 2021 - Springer
Gastrointestinal inflammation is a hallmark of highly prevalent disorders, including cancer
treatment–induced mucositis and ulcerative colitis. These disorders cause debilitating …

[HTML][HTML] Mucositis in patients with hematologic malignancies: an overview

P Niscola, C Romani, L Cupelli, L Scaramucci… - …, 2007 - haematologica.org
Mucosal barrier injury (mucositis) is a common complication of many treatments used in
hematologic malignancies, affecting most patients whose neoplasms are treated with …

Severe oral mucositis after intensity-modulated radiation therapy for head and neck cancer

AJ Iovoli, L Turecki, ML Qiu, M Khan, K Smith… - JAMA Network …, 2023 - jamanetwork.com
Importance Oral mucositis (OM) is a common and debilitating adverse effect observed in
patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous …

Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis

H Saito, Y Watanabe, K Sato, H Ikawa… - Supportive Care in …, 2014 - Springer
Purpose Recent years have seen remarkable progress in cancer therapy, although
treatment-induced adverse reactions and complications are not uncommon. Approximately …